Furthermore, a cross-talk between the two pathways has been described in a model of esophageal cancer where mTORC1/S6K1 promotes the oncogenic function of GLI1, through S6K1-mediated phosphorylation of GLI1, in a SMO-independent manner [57]. Here, SMO is linked to esophageal cancer.